The results of our study have the rate of cathecolamine using (especially noradrenalin) is 95.7% (table 3.4), thrombocytopenia <150 G / L is 50.1% (table 3.7), coagulopathy (rate of prothombine time <60%) is 36.2% (Table 3.7), diabetes insipidus is 70.2% (Table 3.5), kidney failure is 17.1% (Table 3.7), respiratory dysfunction (PaO2/FiO2 < 300) is 33% (table 3.6).